S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
SHOCKING Crypto Leak… (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The "Smart Money" Is Ready for May 1st Are You? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The #1 Crypto for 2024 (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
SHOCKING Crypto Leak… (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The "Smart Money" Is Ready for May 1st Are You? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The #1 Crypto for 2024 (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
SHOCKING Crypto Leak… (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The "Smart Money" Is Ready for May 1st Are You? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The #1 Crypto for 2024 (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
SHOCKING Crypto Leak… (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The "Smart Money" Is Ready for May 1st Are You? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The #1 Crypto for 2024 (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
Free Trial
OTCMKTS:MKGAY

Merck KGaA (MKGAY) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)
Free MKGAY Stock Alerts
$38.36
0.00 (0.00%)
(As of 08/1/2017)
Compare
Today's Range
$38.36
▼
$38.36
50-Day Range
$38.36
▼
$38.36
52-Week Range
$32.53
▼
$42.02
Volume
N/A
Average Volume
6,872 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
MKGAY stock logo

About Merck KGaA Stock (OTCMKTS:MKGAY)

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate and Other. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.

MKGAY Stock Price History

MKGAY Stock News Headlines

March 19, 2024 | msn.com
Merck Highlights Data From Multiple Phase 3 Trials For Its Investigational Pneumococcal Conjugate Vaccine
February 8, 2024 | finanznachrichten.de
Future Scientists in the Making: MilliporeSigma's Curiosity Cube Wraps Up 2023 Multi-Country STEM Tour
April 18, 2024 | Crypto 101 Media (Ad)
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
January 22, 2024 | wsj.com
Merck KGaA
January 3, 2024 | morningstar.com
Merck KGaA ADR MRKC
November 9, 2023 | markets.businessinsider.com
Merck KGaA Q3 Results Down; Now Sees FY23 Earnings In Lower Half Of Estimate Range
October 22, 2023 | msn.com
How This New Merck Regimen Could 'Rewrite Textbooks' In Cancer Treatment — And Bolster 4 Stocks
October 17, 2023 | msn.com
FDA grants expanded approval for Merck's lung cancer drug Keytruda
April 18, 2024 | Crypto 101 Media (Ad)
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
October 16, 2023 | markets.businessinsider.com
EC Approves Merck's KEYTRUDA As Adjuvant Treatment For Non-Small Cell Lung Cancer
October 10, 2023 | msn.com
Merck's Lead Cancer Drug Meets Primary Goal In Certain Type Of Lung Cancer Patients
September 28, 2023 | reuters.com
Merck's blood vessel disorder therapy receives US FDA's priority review
September 25, 2023 | msn.com
Merck and ICR enter renewed cancer drug discovery partnership
September 20, 2023 | markets.businessinsider.com
Exscientia, Merck KGaA To Discover Drug Candidates Across Oncology, Neuroinflammation & Immunology
August 3, 2023 | msn.com
Merck KGaA reports Q2 results
August 3, 2023 | markets.businessinsider.com
Merck KGaA Q2 Results Down, Cuts FY23 View; Backs FY25 Outlook
August 1, 2023 | finance.yahoo.com
Global Cell and Gene Therapy Manufacturing Services Market to 2028, Led by Catalent, Lonza, Merck KGaA, and Thermo Fisher Scientific
July 27, 2023 | benzinga.com
Merck Releases Encouraging Data From Two Late-Stage Studies For Pneumococcal Conjugate Vaccine
July 27, 2023 | msn.com
Moderna/Merck begin late-stage study of mRNA cancer vaccine
May 1, 2023 | msn.com
Barclays Maintains Merck (MRK) Overweight Recommendation
April 27, 2023 | msn.com
Merck Makes a Bold Move That Could Transform Its Business
April 27, 2023 | washingtonpost.com
Merck: Q1 Earnings Snapshot
April 27, 2023 | msn.com
Merck Gains on Q1 Beat
April 26, 2023 | msn.com
Merck Keeps Striking Out on Expanding Its Cancer-Drug Juggernaut
April 12, 2023 | wsj.com
Merck KGaA Shares Fall After US Puts Hold on New Patients in MS Drug Trial
April 10, 2023 | msn.com
Merck (MRK) Keytruda Studies in Difficult-to-Treat Cancers Fail
April 7, 2023 | msn.com
Merck, Eisai end two Keytruda combination trials after missing main goals
See More Headlines
Receive MKGAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceuticals - Major
Sub-Industry
N/A
Current Symbol
OTCMKTS:MKGAY
CUSIP
N/A
CIK
N/A
Web
N/A
Phone
496151720
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover
Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Belén Garijo López
    Chairman-Executive Board & CEO
  • Marcus Kuhnert
    Chief Financial Officer
  • Laura Matz
    Chief Science & Technology Officer
  • Danny Bar-Zohar
    Head-Research & Development
  • Meeta Gulyani
    EVP, Head-Strategy & Business Development

Key Competitors

View All Competitors

MKGAY Stock Analysis - Frequently Asked Questions

Should I buy or sell Merck KGaA stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Merck KGaA in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MKGAY shares.
View MKGAY analyst ratings or view top-rated stocks.

How have MKGAY shares performed in 2024?

Merck KGaA's stock was trading at $38.36 at the beginning of the year. Since then, MKGAY shares have increased by 0.0% and is now trading at $38.36.
View the best growth stocks for 2024 here.

How do I buy shares of Merck KGaA?

Shares of MKGAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:MKGAY) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
SHOCKING Crypto Leak…
Crypto 101 Media
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden replacement revealed?
Paradigm Press
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
How Biden has already won 2024
Porter & Company